US 10703746
Mutant IDH1 inhibitors useful for treating cancer
granted A61KA61K31/435A61K31/437
Quick answer
US patent 10703746 (Mutant IDH1 inhibitors useful for treating cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/435, A61K31/437, A61K31/4375, A61K31/4439